Cargando…
Impact of Pancreatic Resection on Survival in Locally Advanced Resectable Gastric Cancer
SIMPLE SUMMARY: Gastric adenocarcinoma (GC) is the fifth most common malignancy and third leading cause of cancer-related mortality worldwide. Multiorgan resection is necessary to achieve clear R0 margins in GC patients with adjacent organ invasion (T4b). However, whether these patients benefit from...
Autores principales: | Chang, Shih-Chun, Tang, Chi-Ming, Le, Puo-Hsien, Kuo, Chia-Jung, Chen, Tsung-Hsing, Wang, Shang-Yu, Chou, Wen-Chi, Chen, Tse-Ching, Yeh, Ta-Sen, Hsu, Jun-Te |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001184/ https://www.ncbi.nlm.nih.gov/pubmed/33799426 http://dx.doi.org/10.3390/cancers13061289 |
Ejemplares similares
-
Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer
por: Hsu, Jun-Te, et al.
Publicado: (2015) -
Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer
por: Chen, Yi-Fu, et al.
Publicado: (2023) -
Prognostic Significance of Perineural Invasion in Patients with Stage II/III Gastric Cancer Undergoing Radical Surgery
por: Chen, Yi-Fu, et al.
Publicado: (2022) -
Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on “Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553”
por: Chen, Yi-Fu, et al.
Publicado: (2023) -
Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone
por: Huang, Ruo-Yi, et al.
Publicado: (2022)